More on PYXS
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $1.35 |
|
|||
| Open | $1.36 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $1.39 | ||||
| Day Low | $1.33 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 273,556 | ||||
- Form SCHEDULE 13G/A Pyxis Oncology, Inc. Filed by: Laurion Capital Management LP
- Pyxis Oncology appoints Tom Civik as interim CEO
- Form 8-K Pyxis Oncology, Inc. For: Feb 06
- Form 4 Pyxis Oncology, Inc. For: Feb 03 Filed by: Civik Thomas
- Pyxis Oncology names Thomas Civik interim CEO as Sullivan steps down
- Pyxis Oncology Announces Interim CEO Appointment and Leadership Transition to Support Strategic Focus and Program Continuity
- The $225B Precision Sprint: How Big Pharma is Beating the $170B Patent Cliff
- Why Jefferies sees these stocks as standout biotech plays in 2026
- Pyxis Oncology Inc. (PYXS) PT Raised to $7 at H.C. Wainwright
- Pyxis Oncology Inc. (PYXS) PT Lowered to $5 at RBC Capital
Entities mentioned with PYXS
- Twitter | View Related Stories »
- FDA | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Earnings | View Related Stories »
- 13G | View Related Stories »
- Definitive Agreement | View Related Stories »
- Show More...
